Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the fourteen research firms that are covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) – Investment analysts at Zacks Research upped their FY2023 earnings estimates for Charles River Laboratories International in a report released on Wednesday, May 24th. Zacks Research analyst U. Biswas now forecasts that the medical research company will post earnings of $10.22 per share for the year, […]
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 29.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 45,474 shares of the medical research company’s stock after acquiring an additional 10,450 […]
Morningstar Investment Services LLC lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 3.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,655 shares of the medical research company’s stock after purchasing an additional 220 shares […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the fourteen analysts that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price […]